![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Andrew Evens, DO, MBA, MSc
Specialities: Chronic Lymphocytic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Spoken languages: English
Clinical Expertise
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Chronic lymphocytic leukemia
About
I am thrilled to be a member of the Rutgers Cancer Institute of New Jersey as the Associate Director for Clinical Services; System Director of Medical Oncology and Oncology Lead for the Combined Medical Group with RWJBarnabas Health (RWJBH); and Associate Vice Chancellor for Clinical Innovation and Data Analytics, within Rutgers Biomedical and Health Sciences (RBHS). Rutgers Cancer Institute is one of only 53 cancer centers recognized nationally and New Jersey’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center. Our mission is to deliver comprehensive and compassionate cancer care across the health system with access to worldwide expertise and innovative cancer therapies not available elsewhere in the state.
Location
Rutgers Cancer Institute Of New Jersey: 195 Little Albany St, New Brunswick, NJ 08901, USA
Get the latest thought leadership on your T-Cell Prolymphocytic Leukemia delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2024 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811